SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100412-14-000053
Filing Date
2014-09-12
Accepted
2014-09-11 19:26:34
Documents
7
Period of Report
2014-09-11
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a8k91114.htm 8-K 51051
2 EX-10.1 a8k91114ex10d1.htm EX-10.1 52248
3 EX-10.2 a8k91114ex10d2.htm EX-10.2 37344
4 EX-10.3 a8k91114ex10d3.htm EX-10.3 35362
5 EX-10.4 a8k91114ex10d4.htm EX-10.4 103386
6 EX-99.1 a8k91114ex99d1.htm EX-99.1 12439
7 arraylogo2.jpg GRAPHIC 38862
  Complete submission text file 0001100412-14-000053.txt   346739
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 141099254
SIC: 2834 Pharmaceutical Preparations